Inovio Pharmaceuticals, Inc.

8.14 USD
+0.05 (+0.62%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Inovio Pharmaceuticals, Inc. stock is down -25.73% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44% of the previous 24 June’s closed higher than May. In the last 2 Unusual Options Trades, there were 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
13 May 17:39 17 May, 2024 20.00 PUT 70 0
13 May 18:03 17 May, 2024 20.00 PUT 73 0

About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines. Its DNA medicines platform uses precisely designed SynCon that identifies and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.